Gyre Therapeutics Stock Forecast - 4 Period Moving Average

GYRE Stock   11.75  1.16  8.99%   
The 4 Period Moving Average forecasted value of Gyre Therapeutics on the next trading day is expected to be 12.33 with a mean absolute deviation of 0.59 and the sum of the absolute errors of 34.11. Gyre Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Gyre Therapeutics stock prices and determine the direction of Gyre Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Gyre Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, Gyre Therapeutics' Receivables Turnover is projected to decrease significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 7.82, whereas Inventory Turnover is forecasted to decline to 1.03. . The current year's Common Stock Shares Outstanding is expected to grow to about 69.1 M.
A four-period moving average forecast model for Gyre Therapeutics is based on an artificially constructed daily price series in which the value for a given day is replaced by the mean of that value and the values for four preceding and succeeding time periods. This model is best suited to forecast equities with high volatility.

Gyre Therapeutics 4 Period Moving Average Price Forecast For the 23rd of November

Given 90 days horizon, the 4 Period Moving Average forecasted value of Gyre Therapeutics on the next trading day is expected to be 12.33 with a mean absolute deviation of 0.59, mean absolute percentage error of 0.58, and the sum of the absolute errors of 34.11.
Please note that although there have been many attempts to predict Gyre Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Gyre Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Gyre Therapeutics Stock Forecast Pattern

Backtest Gyre TherapeuticsGyre Therapeutics Price PredictionBuy or Sell Advice 

Gyre Therapeutics Forecasted Value

In the context of forecasting Gyre Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Gyre Therapeutics' downside and upside margins for the forecasting period are 7.99 and 16.67, respectively. We have considered Gyre Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
11.75
12.33
Expected Value
16.67
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Gyre Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Gyre Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria112.0496
BiasArithmetic mean of the errors 0.0424
MADMean absolute deviation0.5882
MAPEMean absolute percentage error0.0438
SAESum of the absolute errors34.115
The four period moving average method has an advantage over other forecasting models in that it does smooth out peaks and troughs in a set of daily price observations of Gyre Therapeutics. However, it also has several disadvantages. In particular this model does not produce an actual prediction equation for Gyre Therapeutics and therefore, it cannot be a useful forecasting tool for medium or long range price predictions

Predictive Modules for Gyre Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Gyre Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
7.2511.7116.17
Details
Intrinsic
Valuation
LowRealHigh
6.4610.9215.38
Details
Bollinger
Band Projection (param)
LowMiddleHigh
12.1114.3116.51
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Other Forecasting Options for Gyre Therapeutics

For every potential investor in Gyre, whether a beginner or expert, Gyre Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Gyre Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Gyre. Basic forecasting techniques help filter out the noise by identifying Gyre Therapeutics' price trends.

Gyre Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gyre Therapeutics stock to make a market-neutral strategy. Peer analysis of Gyre Therapeutics could also be used in its relative valuation, which is a method of valuing Gyre Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Gyre Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Gyre Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Gyre Therapeutics' current price.

Gyre Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Gyre Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gyre Therapeutics shares will generate the highest return on investment. By undertsting and applying Gyre Therapeutics stock market strength indicators, traders can identify Gyre Therapeutics entry and exit signals to maximize returns.

Gyre Therapeutics Risk Indicators

The analysis of Gyre Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Gyre Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting gyre stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Gyre Therapeutics is a strong investment it is important to analyze Gyre Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gyre Therapeutics' future performance. For an informed investment choice regarding Gyre Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Gyre Therapeutics to cross-verify your projections.
For information on how to trade Gyre Stock refer to our How to Trade Gyre Stock guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gyre Therapeutics. If investors know Gyre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gyre Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.70)
Earnings Share
(1.04)
Revenue Per Share
1.464
Quarterly Revenue Growth
(0.14)
Return On Assets
0.1018
The market value of Gyre Therapeutics is measured differently than its book value, which is the value of Gyre that is recorded on the company's balance sheet. Investors also form their own opinion of Gyre Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Gyre Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gyre Therapeutics' market value can be influenced by many factors that don't directly affect Gyre Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gyre Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gyre Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gyre Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.